HealthPlix Technologies, a Bengaluru based startup, has raised $6 million in a recently led Series B funding round led by JSW Ventures on Monday. The company’s existing investors including Chiratae Ventures and Kalaari Capital also participated in the round.

This move takes the total investments of the company at $10 million. The health-tech startup is exploring if it could come together with the state governments and bring all COVID-19 disease information on a single platform and assess outcomes.

"We are excited to partner with HealthPlix to build the de-facto technology platform for doctors in India as well as to realise the vision of using medical insights to improve health outcomes. We believe that HealthPlix is uniquely positioned to take advantage of strong tailwinds that the Indian healthcare industry is experiencing in terms of increased medical information capture, interoperability, and automation," Gaurav Sachdeva, Managing Partner of JSW Ventures, said in a statement.

The four-year-old startup was founded in 2016 by Raghuraj Sunder Raju, Prasad Basavaraj, and Sandeep Gudibanda. It claims to provide clinical software for doctors. It has developed an Electronic Medical Record (EMR) software and also assists medical practitioners with its clinical decision support (CDS), helps generate e-prescriptions under 30 seconds, and digitally manage the entire operations of their clinics.

The startup has been helping more than 5,000 doctors digitise their clinical operations and treatment methods.  It has assisted in more than 50,000 consultations on a daily basis, and across 12 medical specialities. It has also developed an IP around the longitudinal representation of a patient's treatment journey, and in delivering actionable clinical decision support to assist medical practitioners in real-time. Since the outbreak of the coronavirus pandemic, HealthPlix claims it has enabled more than 15,000 doctors to offer video consultations.
 
Co-founder and CEO Sandeep Gudibanda said that the company has been helping thousands of doctors in India to elevate their clinical practice to truly an evidence-based treatment methodology using HealthPlix EMR, and now it believes that it can use Real World Evidence (RWE) Platform to assess the efficacy of various treatments being deployed, and thus contribute in the research of coronavirus, the need of the hour.